← Leaderboards
Xiaojuan Li
Harvard Pilgrim Health Care, Inc.
$831,422
Attributed
$831,422
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $290.7K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$831,422 · 2
By mechanism
K01$499,422 · 1
R03$332,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Pilgrim Health Care, Inc.
Same institution · by research overlap
- Darren Toh$4,306,783
Others in their field
Other Emerging Leaders on “Long-Term Effects”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Timothy M Willson · University Of Cape Town$32,741,597
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Andrew S Huhn · Johns Hopkins University$14,521,022
- Xinhua Li · Nano Terra, Inc.$14,470,585
Research focus
Long-Term EffectsTreatment EffectFeedbackLinkPharmaceutical PreparationsSample SizeData SetEventFundingHuman Old Age (65+)ComplexMortalityPreventPublishingAccountingCharacteristicsDesignElderlyFractureFrailtyCaringHospitalizationAreaBenchmarking
Grant awards (6)
Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation$125,280
K01 · FY2025 · AG · contact PI
Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation$124,800
K01 · FY2024 · AG · contact PI
Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation$124,610
K01 · FY2023 · AG · contact PI
Novel causal inference methods to inform clinical decision on when to discontinue symptomatic treatment for patients with dementia$166,000
R03 · FY2022 · AG · contact PI
Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation$124,732
K01 · FY2022 · AG · contact PI
Novel causal inference methods to inform clinical decision on when to discontinue symptomatic treatment for patients with dementia$166,000
R03 · FY2021 · AG · contact PI